About the Advanced Pediatric Thyroid Cancer Therapeutics Clinic

Our Experts

The Advanced Pediatric Thyroid Cancer Therapeutics Clinic at Children’s Hospital of Philadelphia (CHOP) is run by leading experts in Endocrinology and Oncology. In partnership with CHOP’s Center for Precision Medicine for High-Risk Pediatric Cancer and Developmental Therapeutics Program, our multidisciplinary team evaluates and treats pediatric thyroid cancer patients with progressive, refractory (treatment-resistant) disease, who may benefit from newly available targeted and systemic therapies.

Our experts each offer unique expertise that contributes to the management of patients with advanced thyroid cancer in this multidisciplinary clinic.

Andrew J. Bauer, MD, is an internationally recognized expert in the evaluation and treatment of thyroid cancer in children. He serves as Co-chair of the American Thyroid Association’s Pediatric Thyroid Cancer Guidelines Taskforce for the evaluation and management of differentiated thyroid cancer in children.

Theodore W. Laetsch, MD, is an internationally recognized expert in the evaluation and treatment of rare tumors and in developmental therapeutics. Dr. Laetsch leads several multi-center clinical trials of targeted therapies for cancer patients with advanced disease, including those whose tumors are driven by alterations in the RET, NTR and ALK genes.

Sogol (Goli) Mostoufi-Moab, MD, MSCE, is dual-board certified in pediatric endocrinology and oncology, and an internationally recognized expert in the evaluation and management of patients with endocrine complications associated with oncologic therapy.

Both Drs. Laetsch and Mostoufi-Moab serve on the Children’s Oncology Group Rare Tumors committee.